Takeda backs biomarker trial for Crohn's prevention

A pioneering clinical trial backed by the EU and drugmaker Takeda will look for biomarkers that could be used to identify people at risk of developing Crohn's disease in the hope of intervening early on to prevent symptoms ever developing.